# Induction of Cross-protective Antibodies for Serogroup 33 by Pneumococcal Conjugate Vaccines

> **NCT07135453** · PHASE4 · RECRUITING · sponsor: **University of Alabama at Birmingham** · enrollment: 70 (estimated)

## Conditions studied

- Vaccine
- Pneumococcal Disease

## Interventions

- **BIOLOGICAL:** Pneumococcal Vaccine

## Key facts

- **NCT ID:** NCT07135453
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2027-03
- **Final completion:** 2027-08
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2026-05-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07135453

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07135453, "Induction of Cross-protective Antibodies for Serogroup 33 by Pneumococcal Conjugate Vaccines". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07135453. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*